Adavosertib

CAT: 0804-HY-10993-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-10993-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Adavosertib (AZD-1775; MK-1775) is a potent Wee1 inhibitor with an IC50 of 5.2 nM.
CAS Number
[955365-80-7]
Product Name Alternative
AZD1775; MK-1775
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Wee1
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/MK-1775.html
Purity
99.96
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1N(N(C2=NC(NC3=CC=C(C=C3)N4CCN(CC4)C)=NC=C21)C5=NC(C(O)(C)C)=CC=C5)CC=C
Molecular Formula
C27H32N8O2
Molecular Weight
500.60
Precautions
H315, H319, H335
References & Citations
[1]Hirai H, et al. MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-FU. Cancer Biol Ther. 2010 Apr;9 (7) :514-22.|[2]Bridges KA, et al. MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Clin Cancer Res. 2011 Sep 1;17 (17) :5638-48. Epub 2011 Jul 28.|[3]Rajeshkumar NV, et al. MK-1775, a potent Wee1 inhibitor, synergizes with NSC 613327 to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts.Clin Cancer Res. 2011 May 1;17 (9) :2799-806. Epub 2011 Mar 9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2

Alternative Products

CatalogName
M16820-01Adavosertib
BA4565-1Pomalidomide-C3-adavosertib
C16368-01Adavosertib (MK-1775)
A24453-50Pomalidomide-C3-adavosertib 50mg
A10599-5Adavosertib (MK-1775) 5mg
A10599-100Adavosertib (MK-1775) 100mg
A10599-200Adavosertib (MK-1775) 200mg
A24453-5Pomalidomide-C3-adavosertib 5mg
A10599-10Adavosertib (MK-1775) 10mg
A24453-1Pomalidomide-C3-adavosertib 1mg

Popular Products